"The landscape of checkpoint inhibitors in…

Jan 30

How many patients are eligible for and respond to checkpoint inhibitors? Here is our eagerly awaited updated analysis, now also including the regulatory context.

Read →

1 Comment

medstudent

Jan 30

GREAT work! Really looking forward to digging into it! Thank you

Expand full comment

Reply

Share

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts